0001062993-23-021913.txt : 20231205 0001062993-23-021913.hdr.sgml : 20231205 20231205161143 ACCESSION NUMBER: 0001062993-23-021913 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231201 FILED AS OF DATE: 20231205 DATE AS OF CHANGE: 20231205 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Grade Joel T. CENTRAL INDEX KEY: 0001602507 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-04448 FILM NUMBER: 231466702 MAIL ADDRESS: STREET 1: SYSCO CORPORATION STREET 2: 1390 ENCLAVE PARKWAY CITY: HOUSTON STATE: TX ZIP: 77077 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BAXTER INTERNATIONAL INC CENTRAL INDEX KEY: 0000010456 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 360781620 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE BAXTER PKWY STREET 2: DF2-1W CITY: DEERFIELD STATE: IL ZIP: 60015 BUSINESS PHONE: 8479482000 MAIL ADDRESS: STREET 1: ONE BAXTER PARKWAY STREET 2: DF2-1W CITY: DEERFIELD STATE: IL ZIP: 60015 FORMER COMPANY: FORMER CONFORMED NAME: BAXTER TRAVENOL LABORATORIES INC DATE OF NAME CHANGE: 19880522 FORMER COMPANY: FORMER CONFORMED NAME: BAXTER LABORATORIES INC DATE OF NAME CHANGE: 19760608 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0508 4 2023-12-01 0000010456 BAXTER INTERNATIONAL INC BAX 0001602507 Grade Joel T. ONE BAXTER PARKWAY DEERFIELD IL 60015 0 1 0 0 EVP and CFO 0 Common Stock, $1 par value 2023-12-01 4 A 0 27988 0 A 27988 D Common Stock, $1 par value 2023-12-01 4 A 0 25189 0 A 53177 D Stock Option (Right to Buy) 36.55 2023-12-01 4 A 0 102273 0 A 2033-12-01 Common Stock, $1 par value 102273 102273 D The reporting person received a restricted stock unit grant which is scheduled to vest in three equal annual installments beginning on December 2, 2024, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan. The reporting person received a restricted stock unit grant which is scheduled to vest in three equal annual installments beginning on December 2, 2024, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan. The options become exercisable in three equal annual installments beginning on December 2, 2024, the first anniversary of the grant date. /s/ Matthew Rice, as attorney in-fact for Joel T. Grade 2023-12-05